Search results for "marijuana"

showing 10 items of 41 documents

Is physical activity associated with low-risk health behaviours among 15-year-old adolescents in Finland?

2012

Aims: To investigate the associations between physical activity and the pattern of risk health behaviour consisting of smoking, alcohol consumption, snuff (snus), cannabis, and condom use among 15-year-old adolescents, taking their educational aspirations and family affluence into account. Methods: The data were collected in the Health Behaviour in School-aged Children (HBSC) study in Finland in 2006. Standardised questionnaires were issued at schools to a 15-year-old nationally representative sample, of which 84.5% (1710 pupils) participated. Logistic regression analysis was used to explore the associations between physical activity, pattern of risk health behaviour, family affluence, and…

MaleMarijuana AbuseCross-sectional studyHealth Behaviorphysical activityfamily affluencelaw.inventionCondomsnuoretlawMedicineFinlandeducation.field_of_studybiologyexerciseSmokingAge Factorsta3141General MedicineTobacco Use Disorderriskitekijärisk factorSnusEducational StatusFemaleFamily Relationsmedicine.medical_specialtyTobacco SmokelessAlcohol DrinkingAdolescentPopulationMotor Activityterveyden edistäminenRisk-TakingSex FactorsCondomliikunta-aktiivisuusEnvironmental healthHumansSnuffRisk factorperheen koettu varallisuusPsychiatryeducationbusiness.industryPublic Health Environmental and Occupational Healthbiology.organism_classificationfyysinen harjoitteluHealth promotionCross-Sectional StudiesAdolescent BehaviorCannabisbusiness
researchProduct

The Maudsley Environmental Risk Score for Psychosis

2018

AbstractBackgroundRisk prediction algorithms have long been used in health research and practice (e.g. prediction of cardiovascular disease and diabetes). However, similar tools have not been developed for mental health. For example, for psychotic disorders, attempts to sum environmental risk are rare, unsystematic and dictated by available data. In light of this, we sought to develop a valid, easy to use measure of the aggregate environmental risk score (ERS) for psychotic disorders.MethodsWe reviewed the literature to identify well-replicated and validated environmental risk factors for psychosis that combine a significant effect and large-enough prevalence. Pooled estimates of relative r…

MaleMarijuana AbusePsychosisUrban PopulationPopulationEthnic groupDiseaseEnvironmentRisk AssessmentPaternal Agerisk prediction03 medical and health sciences0302 clinical medicineAdverse Childhood ExperiencesPregnancyRisk FactorsEnvironmental healthEthnicitymedicineHumanspsychosisRisk factoreducationMinority GroupsApplied Psychologyeducation.field_of_studybusiness.industryOriginal ArticlesOdds ratiomedicine.diseaseMental healthObstetric Labor Complications3. Good health030227 psychiatryschizophreniaPsychiatry and Mental healthPsychotic DisordersSchizophreniaRelative riskFemaleliabilitybusiness030217 neurology & neurosurgery
researchProduct

The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.

2019

Background: Cannabis use is associated with increased risk of later psychotic disorder but whether it affects incidence of the disorder remains unclear. We aimed to identify patterns of cannabis use with the strongest effect on odds of psychotic disorder across Europe and explore whether differences in such patterns contribute to variations in the incidence rates of psychotic disorder. Methods: We included patients aged 18–64 years who presented to psychiatric services in 11 sites across Europe and Brazil with first-episode psychosis and recruited controls representative of the local populations. We applied adjusted logistic regression models to the data to estimate which patterns of canna…

MaleMarijuana Abusecannabis psychosis first episode psychosis incidenceENGLANDHIGH-POTENCY CANNABIS0302 clinical medicineSCHIZOPHRENIAOdds RatioMedicine030212 general & internal medicinepsychosisSalut mentalRISKeducation.field_of_studybiologyIncidence (epidemiology)IncidenceArticlesASSOCIATIONMiddle Aged3. Good healthEuropePsychiatry and Mental healthPUBLIC-HEALTHFemaleCase-Control StudieBrazilHumanAdultmedicine.medical_specialtyPsychosisPopulationPsychotic DisorderOdds03 medical and health sciencesYoung Adultfirst episode psychosisJournal ArticleHumanseducationSettore MED/25 - PsichiatriaBiological PsychiatryCannabisbusiness.industryLONDONPublic healthCase-control studyOdds ratiobiology.organism_classificationmedicine.diseaseTRENDS030227 psychiatryPsychotic DisordersMARIJUANACase-Control StudiesCannabisDroguesbusinessDemography
researchProduct

Estimating Exposome Score for Schizophrenia Using Predictive Modeling Approach in Two Independent Samples: The Results From the EUGEI Study

2019

The EUGEI project was supported by the grant agreement HEALTH-F2-2010-241909 from the European Community’s Seventh Framework Programme. The authors are grateful to the patients and their families for participating in the project. They also thank all research personnel involved in the GROUP project, in particular J. van Baaren, E. Veermans, G. Driessen, T. Driesen, E. van’t Hag and J. de Nijs. Bart PF Rutten was funded by a VIDI award number 91718336 from the Netherlands Scientific Organisation.

MalecannabisLogistic regression0302 clinical medicineLasso (statistics)Adverse Childhood ExperiencesStatisticsOdds RatioChild AbusePOLYGENIC RISKpsychosisChildPsychiatrySUMMER BIRTHFramingham Risk Score3. Good healthExposomePsychiatry and Mental healthmachine learningSchizophreniaArea Under CurveFemaleMarijuana UseSeasonsEnvironment And Schizophrenia—Feature Editor: Jim van OsLife Sciences & Biomedicineenvironmentpredictive modelingAdultExposomeDISORDERSrisk scoreYoung Adult03 medical and health sciencesPSYCHOSISmedicineJournal ArticleHumansHearing LossMETAANALYSISDEFICIT SCHIZOPHRENIAENVIRONMENTModels StatisticalScience & Technologychildhood traumaReceiver operating characteristicbusiness.industrySiblingsBullyingBayes TheoremChild Abuse SexualOdds ratiohearing impairmentmedicine.disease030227 psychiatryschizophreniaLogistic ModelsROC CurveSexual abuseCase-Control StudiesbusinessCHILDHOOD ADVERSITIES030217 neurology & neurosurgerywinter birth
researchProduct

Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use

2020

Abstract Psychotic patients with a lifetime history of cannabis use generally show better cognitive functioning than other psychotic patients. Some authors suggest that cannabis-using patients may have been less cognitively impaired and less socially withdrawn in their premorbid life. Using a dataset comprising 948 patients with first-episode psychosis (FEP) and 1313 population controls across 6 countries, we examined the extent to which IQ and both early academic (Academic Factor [AF]) and social adjustment (Social Factor [SF]) are related to the lifetime frequency of cannabis use in both patients and controls. We expected a higher IQ and a better premorbid social adjustment in psychotic p…

MalecognitionIntelligenceComorbiditySUBSTANCE USE DISORDERS0302 clinical medicineSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.MedicinePREDICTORSRISKeducationeducation.field_of_studybiologyCognitionMiddle AgedPsychosocial FunctioningsociabilityPsychiatry and Mental healthSchizophreniaFemaleMarijuana UseSocial AdjustmentMENTAL-HEALTHAdultmedicine.medical_specialtyPsychosisAdolescentPopulation1ST EPISODEDRUG-USEpreillnessSettore MED/01 - Statistica MedicaYoung Adult03 medical and health sciencesAGESettore M-PSI/08 - Psicologia ClinicaHumansCognitive skilleducationPsychiatrySettore MED/25 - Psichiatriabusiness.industryCase-control studypreillnebiology.organism_classificationmedicine.diseaseEDUCAÇÃO030227 psychiatryschizophreniaPsychotic DisordersCase-Control StudiesONSETCannabisNEUROCOGNITIONbusinessmarijuanaNeurocognitive030217 neurology & neurosurgeryRegular ArticlesSchizophrenia Bulletin
researchProduct

Cannabis use in male and female first episode of non-affective psychosis patients: long-term clinical, neuropsychological and functional differences

2017

BACKGROUND: Numerous studies show the existence of a high prevalence of cannabis use among patients with psychosis. However, the differences between men and women who debut with a first episode of psychosis (FEP) regarding cannabis use have not been largely explored. The aim of this study was to identify the specific sex factors and differences in clinical evolution associated with cannabis use. METHOD: Sociodemographic characteristics at baseline were considered in our sample of FEP patients to find differences depending on sex and the use of cannabis. Clinical, functional and neurocognitive variables at baseline, 1-year, and 3-years follow-up were also explored. RESULTS: A total of 549 pa…

Malelcsh:MedicineSocial Sciences[ SCCO.PSYC ] Cognitive science/PsychologyNeuropsychological TestsDrug UsersCognitionLearning and Memory0302 clinical medicineMedicine and Health SciencesPsychologyYoung adultlcsh:ScienceFirst episodeMultidisciplinarybiologyNeuropsychologyCognitionAddicts3. Good healthBehavioral PharmacologySchizophrenia[ SCCO.NEUR ] Cognitive science/Neuroscience[SCCO.PSYC]Cognitive science/Psychology[SCCO.PSYC] Cognitive science/PsychologyFemaleResearch ArticleAdultPsychosismedicine.medical_specialtyCognitive NeurosciencePsicosiAddictionMarijuana SmokingYoung Adult03 medical and health sciencesMemoryRecreational Drug UseCànnabisMental Health and PsychiatrymedicineHumansFactors sexuals en les malaltiesWorking MemoryPsychiatryCannabisPharmacologybusiness.industry[SCCO.NEUR]Cognitive science/Neuroscience[SCCO.NEUR] Cognitive science/Neurosciencelcsh:RCognitive PsychologyBiology and Life SciencesPsychosesmedicine.diseasebiology.organism_classification030227 psychiatryPsychotic DisordersSchizophreniaCognitive ScienceSex factors in diseaselcsh:QCannabisbusinessNeurocognitive030217 neurology & neurosurgeryNeuroscience
researchProduct

Association between cannabis use and sexual behavior among adolescents aged 12-15 years in 21 low- and middle-income countries.

2019

Abstract Aims To investigate the relationship between cannabis use and two sexual behaviors (ever had sex, multiple partners) in a large representative sample of adolescents aged 12–15 years from 21 low- and-middle income countries. Methods Data from 84,867 adolescents aged 12–15 years participating in the Global School-based Student Health Survey were analyzed. Participants reported lifetime frequency of cannabis use (analyzed as 0, 1–2, 3–19 or ≥ 20 times), whether they had ever had sexual intercourse (yes/no) and, if yes, their lifetime number of sexual partners. We used multivariable logistic regression to analyze associations, adjusting for a range of relevant covariates. Results 12.7%…

Malemedicine.medical_specialtyAdolescentSexual Behavior030508 substance abuseMedicine (miscellaneous)ToxicologyLogistic regressionOdds03 medical and health sciences0302 clinical medicineEpidemiologyMedicineHumans030212 general & internal medicineAssociation (psychology)ChildDeveloping Countriesbiologybusiness.industryCoitusOdds ratiobiology.organism_classificationPsychiatry and Mental healthClinical PsychologySexual intercourseSexual PartnersSexual behaviorFemaleMarijuana UseCannabis0305 other medical sciencebusinessDemographyAddictive behaviors
researchProduct

Tobacco, Cannabis, and Other Illicit Drug Use Among Finnish Adolescent Twins: Causal Relationship or Correlated Liabilities?*

2010

Contains fulltext : 90566.pdf (Publisher’s version ) (Open Access) Objective: Among Finnish adolescent twins, we compared (a) a model that describes a direct impact of liability to tobacco use on cannabis and other illicit drug use with (b) a model that included a shared underlying liability for these substances. Furthermore, the extent to which genetic and environmental influences contribute to the covariation between liabilities to use these substances was examined. Method: Tobacco and illicit drug use were assessed at age 17.5 years. Twin data on 3,744 individuals were analyzed using standard biometrical methods. Two alternative multivariate models were fit and compared with Mx, a statis…

Malemedicine.medical_specialtyMarijuana AbuseHealth (social science)Recreational DrugAdolescentSubstance-Related DisordersTwinsMarijuana SmokingToxicologySocial EnvironmentCohort Studies03 medical and health sciencesYoung Adult0302 clinical medicineEnvironmental healthGenetic modelmental disordersmedicineIllicit drugHumans030212 general & internal medicinePsychiatryFinlandTobacco and other drugsbiologybusiness.industryIllicit DrugsSmokingAge FactorsTargeted interventionsbiology.organism_classificationmedicine.diseaseCausality3. Good healthSubstance abusePsychiatry and Mental healthFemaleCannabisbusinessDevelopmental Psychopathology030217 neurology & neurosurgeryResearch Article
researchProduct

Adverse effects of heavy cannabis use: even plants can harm the brain.

2020

The spread of laws legalising cannabis for medicinal or recreational use has been accompanied by more relaxed attitudes towards cannabis. Data from the United States show that in states that have legalised cannabis, prevalence of daily, weekly, and monthly cannabis use was 11.3%, 18.3%, and 25.0% respectively, whereas in countries where it is still illegal, it was lower (7.4%, 11.6%, and 16.8% respectively). Evidence indicates a trend of increase among adolescents, a particular vulnerable category for the initiation of substance use. In parallel, we have seen the concentration of THC (D-9-tetrahydrocannabinol) in the cannabis sold both in the United States and in Europe rising and those typ…

Marijuana AbuseDrug-Related Side Effects and Adverse Reactionsbusiness.industryheavy cannabis useMEDLINEBrainCannabis useAdverse effectAnesthesiology and Pain MedicineHarmNeurologyEnvironmental healthSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.MedicineNeurology (clinical)Topical ReviewbusinessAdverse effectSettore MED/25 - PsichiatriaCannabisPain
researchProduct

Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: The EU-GEI case-control study

2021

The work was supported by: Clinician Scientist Medical Research Council fellowship (project reference MR/M008436/1) to MDF; the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South London at King’s College Hospital NHS Foundation Trust to DQ; DFG Heisenberg professorship (no. 389624707) to UR. National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health at South London and Maudsley NHS Foundation Trust and King’s College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. The EU-GEI Project is funded by t…

Marijuana AbuseIMPACTPoison controlCannabis usecannabis-associated psychosis0302 clinical medicineSCHIZOPHRENIASettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.health care economics and organizationsApplied PsychologyRISKOUTCOMESbiologyHuman factors and ergonomics/dk/atira/pure/subjectarea/asjc/2700/2738psychopathologyCannabis use; cannabis-associated psychosis; first episode psychosis; psychopathology; psychotic experiences; symptom dimensions3. Good healthPsychiatry and Mental healthSchizophreniaHEALTHPsychopathologyPsychosismedicine.medical_specialtyDISORDERSeducationsymptom dimensions03 medical and health sciencesInjury preventionfirst episode psychosismedicineHumanspsychotic experiencesPsychiatryABUSESettore MED/25 - PsichiatriaSUBSTANCE USEMETAANALYSISCannabisbusiness.industryCase-control studyOriginal Articlesmedicine.diseasebiology.organism_classification030227 psychiatrypsychotic experiencePsychotic Disordersfirst episode psychosiCase-Control StudiesONSETGene-Environment Interaction/dk/atira/pure/subjectarea/asjc/3200/3202Cannabisbusinesscannabis-associated psychosi030217 neurology & neurosurgery
researchProduct